Shenzhen Salubris Pharmaceuticals Co Ltd (SZSE:002294) Share Price

Company Profile

Business description
Shenzhen Salubris Pharmaceuticals Co Ltd is a pharmaceutical company dedicated to the research, development, and sale of medical products for cardiovascular diseases, cephalous antibiotics, and bone resorption inhibitors. Its products mainly focused on the areas of cardio-cerebral vascular disease, diabetes, and complications, anti-tumor, and orthopedics, Its business lines include high-end chemical drugs, biological drugs, and medical devices. Its businesses are located in China, the United States, Germany, France, and Japan, and other countries and regions.
Contact
No. 6009 Shennan Road
37th Floor, Main Building, Chegongmiao Lvjing Plaza
Futian District, Guangdong
Shenzhen518040
CHN
T: +86 75583867888
https://www.salubris.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2025
Employees
3,596

Recommended

Qantas’ pandemic woes seem a distant memory. But could the party end sooner than investors think?

Joseph Taylor | 06 August 2025

We raise our fair value estimate off the back of earnings.

Mark Giarelli | 05 August 2025

Strong demand growth and improved profit margins lead to a strong result from the sleep apnea device firm.

Shane Ponraj, CFA | 05 August 2025

Index	Last price	Change	% Change
All Ordinaries	9,087.30	58.50	0.65%
CAC 40	7,621.04	10.97	-0.14%
DAX 40	23,846.07	88.38	0.37%
Dow JONES (US)	44,111.74	61.90	-0.14%
FTSE 100	9,142.73	14.43	0.16%
HKSE	24,947.45	44.92	0.18%
NASDAQ	20,916.55	137.03	-0.65%
Nikkei 225	40,736.87	187.33	0.46%
NZX 50 Index	12,893.37	16.33	0.13%
S&P 500	6,299.19	30.75	-0.49%
S&P/ASX 200	8,819.80	49.40	0.56%
SSE Composite Index	3,627.54	9.94	0.27%